Nothing Special   »   [go: up one dir, main page]

Cameron et al., 1998 - Google Patents

Developmental regulation of neuronal K+ channels by target-derived TGFβ in vivo and in vitro

Cameron et al., 1998

View HTML @Full View
Document ID
5131805936572682499
Author
Cameron J
Lhuillier L
Subramony P
Dryer S
Publication year
Publication venue
Neuron

External Links

Snippet

The functional expression of Ca 2+-activated K+ channels (K Ca) in developing chick ciliary ganglion (CG) neurons requires interactions with target tissues and preganglionic innervation. Here, we show that the stimulatory effects of target tissues are mediated by an …
Continue reading at www.cell.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Similar Documents

Publication Publication Date Title
Cameron et al. Developmental regulation of neuronal K+ channels by target-derived TGFβ in vivo and in vitro
Ringstedt et al. BDNF regulates reelin expression and Cajal-Retzius cell development in the cerebral cortex
Todd et al. Efficient stimulation of retinal regeneration from Müller glia in adult mice using combinations of proneural bHLH transcription factors
Wang et al. Potentiation of developing synapses by postsynaptic release of neurotrophin-4
Fornasiero et al. The role of synapsins in neuronal development
Blondel et al. A glia-derived signal regulating neuronal differentiation
Spitzer Neurotransmitter switching? No surprise
Nawabi et al. Doublecortin-like kinases promote neuronal survival and induce growth cone reformation via distinct mechanisms
Nassenstein et al. Phenotypic distinctions between neural crest and placodal derived vagal C‐fibres in mouse lungs
Buldyrev et al. Calcitonin gene‐related peptide enhances release of native brain‐derived neurotrophic factor from trigeminal ganglion neurons
Lockhart et al. Nerve growth factor modulates synaptic transmission between sympathetic neurons and cardiac myocytes
Ma et al. Distinct subtypes of somatostatin-containing neocortical interneurons revealed in transgenic mice
Bourane et al. Low-threshold mechanoreceptor subtypes selectively express MafA and are specified by Ret signaling
Belecky‐Adams et al. Developmental expression patterns of bone morphogenetic proteins, receptors, and binding proteins in the chick retina
Lilley et al. SAD kinases sculpt axonal arbors of sensory neurons through long-and short-term responses to neurotrophin signals
Waetzig et al. MEKK1 controls neurite regrowth after experimental injury by balancing ERK1/2 and JNK2 signaling
Schenk et al. A novel pathway for presynaptic mitogen-activated kinase activation via AMPA receptors
Goetzl et al. Deficient neurotrophic factors of CSPG4-type neural cell exosomes in Alzheimer disease
Yang et al. Interneuron development and dysfunction
Balia et al. A specific GABAergic synapse onto oligodendrocyte precursors does not regulate cortical oligodendrogenesis
Walter et al. The Parkinson’s-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1
Ulmann et al. Trophic effects of keratinocytes on the axonal development of sensory neurons in a coculture model
Kilpatrick et al. Nuclear factor I and cerebellar granule neuron development: an intrinsic–extrinsic interplay
Lanuza et al. Pertussis toxin‐sensitive G‐protein and protein kinase C activity are involved in normal synapse elimination in the neonatal rat muscle
Sarafian et al. Stimulation of synaptoneurosome glutamate release by monomeric and fibrillated α‐synuclein